These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37979905)

  • 1. Characterization of neural damage and neuroinflammation in Pax6 small-eye mice.
    Cole JD; McDaniel JA; Nilak J; Ban A; Rodriguez C; Hameed Z; Grannonico M; Netland PA; Yang H; Provencio I; Liu X
    Exp Eye Res; 2024 Jan; 238():109723. PubMed ID: 37979905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term retinal protection by MEK inhibition in Pax6 haploinsufficiency mice.
    Cole JD; McHaney KM; Rabiee B; Gao J; Rodriguez C; Miller DA; Liu M; Grannonico M; Norat P; Zhang HF; Djalilian AR; Liu X
    Exp Eye Res; 2022 May; 218():109012. PubMed ID: 35245513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistasis between Pax6
    Hickmott JW; Gunawardane U; Jensen K; Korecki AJ; Simpson EM
    Gene Ther; 2018 Dec; 25(8):524-537. PubMed ID: 30258099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological characterisation of effects of the mouse Pax6(Leca4) missense mutation on eye development.
    Ramaesh T; Williams SE; Paul C; Ramaesh K; Dhillon B; West JD
    Exp Eye Res; 2009 Aug; 89(2):263-73. PubMed ID: 19345209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis and genotype-phenotype correlations in southern Indian patients with sporadic and familial aniridia.
    Dubey SK; Mahalaxmi N; Vijayalakshmi P; Sundaresan P
    Mol Vis; 2015; 21():88-97. PubMed ID: 25678763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three new PAX6 mutations including one causing an unusual ophthalmic phenotype associated with neurodevelopmental abnormalities.
    Dansault A; David G; Schwartz C; Jaliffa C; Vieira V; de la Houssaye G; Bigot K; Catin F; Tattu L; Chopin C; Halimi P; Roche O; Van Regemorter N; Munier F; Schorderet D; Dufier JL; Marsac C; Ricquier D; Menasche M; Penfornis A; Abitbol M
    Mol Vis; 2007 Apr; 13():511-23. PubMed ID: 17417613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aniridia-associated translocations, DNase hypersensitivity, sequence comparison and transgenic analysis redefine the functional domain of PAX6.
    Kleinjan DA; Seawright A; Schedl A; Quinlan RA; Danes S; van Heyningen V
    Hum Mol Genet; 2001 Sep; 10(19):2049-59. PubMed ID: 11590122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenopus pax6 mutants affect eye development and other organ systems, and have phenotypic similarities to human aniridia patients.
    Nakayama T; Fisher M; Nakajima K; Odeleye AO; Zimmerman KB; Fish MB; Yaoita Y; Chojnowski JL; Lauderdale JD; Netland PA; Grainger RM
    Dev Biol; 2015 Dec; 408(2):328-44. PubMed ID: 25724657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene dosage manipulation alleviates manifestations of hereditary
    Rabiee B; Anwar KN; Shen X; Putra I; Liu M; Jung R; Afsharkhamseh N; Rosenblatt MI; Fishman GA; Liu X; Ghassemi M; Djalilian AR
    Sci Transl Med; 2020 Dec; 12(573):. PubMed ID: 33298563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel mutant PAX6 alleles in Indian cases of familial aniridia.
    Neethirajan G; Nallathambi J; Krishnadas SR; Vijayalakshmi P; Shashikanth S; Collinson JM; Sundaresan P
    BMC Ophthalmol; 2006 Jun; 6():28. PubMed ID: 16803629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal abnormalities in Pax6+/- small eye mice mimic human aniridia-related keratopathy.
    Ramaesh T; Collinson JM; Ramaesh K; Kaufman MH; West JD; Dhillon B
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):1871-8. PubMed ID: 12714618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The requirement of pax6 for postnatal eye development: evidence from experimental mouse chimeras.
    Li S; Goldowitz D; Swanson DJ
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3292-300. PubMed ID: 17591901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphthalmia, late onset keratitis, and iris coloboma/aniridia in a family with a novel PAX6 mutation.
    Xiao X; Li S; Zhang Q
    Ophthalmic Genet; 2012 Jun; 33(2):119-21. PubMed ID: 22171686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited PAX6, NF1 and OTX2 mutations in a child with microphthalmia and aniridia.
    Henderson RA; Williamson K; Cumming S; Clarke MP; Lynch SA; Hanson IM; FitzPatrick DR; Sisodiya S; van Heyningen V
    Eur J Hum Genet; 2007 Aug; 15(8):898-901. PubMed ID: 17406642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EPHA2 biallelic disruption causes syndromic complex microphthalmia with iris hypoplasia.
    Courdier C; Gemahling A; Guindolet D; Barjol A; Scaramouche C; Bouneau L; Calvas P; Martin G; Chassaing N; Plaisancié J
    Eur J Med Genet; 2022 Oct; 65(10):104574. PubMed ID: 35918037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of canine PAX6 and evaluation as a candidate gene in a canine model of aniridia.
    Hunter LS; Sidjanin DJ; Hijar MV; Johnson JL; Kirkness E; Acland GM; Aguirre GD
    Mol Vis; 2007 Mar; 13():431-42. PubMed ID: 17417604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of dominant FOXE3 and PAX6 mutations in patients with congenital cataract and aniridia.
    Brémond-Gignac D; Bitoun P; Reis LM; Copin H; Murray JC; Semina EV
    Mol Vis; 2010 Aug; 16():1705-11. PubMed ID: 20806047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX6 mutation in association with ptosis, cataract, iris hypoplasia, corneal opacification and diabetes: a new variant of familial aniridia?
    Peter NM; Leyland M; Mudhar HS; Lowndes J; Owen KR; Stewart H
    Clin Exp Ophthalmol; 2013 Dec; 41(9):835-41. PubMed ID: 23566044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects.
    Gregory-Evans CY; Wang X; Wasan KM; Zhao J; Metcalfe AL; Gregory-Evans K
    J Clin Invest; 2014 Jan; 124(1):111-6. PubMed ID: 24355924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Pax6 results in microphthalmia, retinal dysplasia and defective retinal ganglion cell axon guidance.
    Manuel M; Pratt T; Liu M; Jeffery G; Price DJ
    BMC Dev Biol; 2008 May; 8():59. PubMed ID: 18507827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.